Extended Half-life rFVIII for the Treatment of Hemophilia A: Drugs Consumption and Patients’ Perspective. FE [Internet]. 2020 Jun. 16 [cited 2025 Oct. 28];21(1). Available from: https://journals.seedstm.com/index.php/FE/article/view/1472